Explore › Intervention › Intrathecal consolidation chemotherapy
Intervention

Intrathecal consolidation chemotherapy

Also known as: Intrathecal consolidation chemotherapy after achieving CNS complete remission (5 or more IT treatments vs 1-4 vs none) CR
3 findings 1 paper 3 related entities View in graph →

Related entities

conditions
Central nervous system1
outcomes
overall survival1
studys
PMC87117231

Findings (27)

None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →
None
improvement

Patients with CNS leukemia who received intrathecal consolidation chemotherapy after achieving CNS complete remission had significantly improved 3-year overall survival in a dose-dependent pattern com

Effect: improvement; 61% vs. 53% vs. 13%

Size: 61% vs. 53% vs. 13%
PMC8711723
Finding details → · Paper → · Graph →

Papers (1)